ARID4B and metabolic syndrome: The mRNA abundance of BCAA catabolic enzymes has been reported to be markedly reduced in omental (but not subcutaneous) white adipose tissue of obese individuals with metabolic syndrome compared with weight-matched healthy obese subjects, raising the possibility that visceral adipose tissue contributes to the BCAA metabolic phenotype of metabolically compromised individuals [36].